Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 5 studies | 71% ± 26% | |
endothelial cell of sinusoid | 3 studies | 40% ± 19% | |
endothelial cell | 3 studies | 45% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 57% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 322484.67 | 226 / 226 | 99% | 6219.52 | 400 / 406 |
lung | 91% | 568.18 | 526 / 578 | 42% | 24.28 | 483 / 1155 |
spleen | 95% | 1276.07 | 228 / 241 | 0% | 0 | 0 / 0 |
stomach | 74% | 218.14 | 264 / 359 | 21% | 44.06 | 59 / 286 |
prostate | 55% | 1089.71 | 134 / 245 | 35% | 570.73 | 175 / 502 |
peripheral blood | 83% | 1921.10 | 770 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 76% | 211.85 | 197 / 258 | 6% | 5.96 | 13 / 230 |
pancreas | 45% | 89.58 | 146 / 328 | 16% | 11.03 | 29 / 178 |
breast | 34% | 130.58 | 157 / 459 | 23% | 32.49 | 254 / 1118 |
lymph node | 0% | 0 | 0 / 0 | 45% | 304.63 | 13 / 29 |
adipose | 42% | 188.65 | 502 / 1204 | 0% | 0 | 0 / 0 |
uterus | 31% | 27.15 | 53 / 170 | 8% | 3.73 | 39 / 459 |
ovary | 29% | 24.11 | 52 / 180 | 9% | 2.16 | 38 / 430 |
bladder | 29% | 18.33 | 6 / 21 | 8% | 5.69 | 41 / 504 |
intestine | 23% | 28.78 | 224 / 966 | 12% | 56.42 | 65 / 527 |
esophagus | 24% | 34.62 | 344 / 1445 | 11% | 27.62 | 20 / 183 |
thymus | 29% | 31.40 | 190 / 653 | 3% | 5.52 | 19 / 605 |
kidney | 20% | 15.34 | 18 / 89 | 3% | 5.17 | 25 / 901 |
heart | 22% | 28.82 | 193 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 22% | 25.04 | 288 / 1335 | 0% | 0 | 0 / 0 |
muscle | 19% | 20.82 | 151 / 803 | 0% | 0 | 0 / 0 |
skin | 14% | 21.45 | 254 / 1809 | 3% | 0.89 | 15 / 472 |
brain | 11% | 9.95 | 286 / 2642 | 2% | 1.06 | 13 / 705 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.21 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0006953 | Biological process | acute-phase response |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0006954 | Biological process | inflammatory response |
GO_0002682 | Biological process | regulation of immune system process |
GO_0032732 | Biological process | positive regulation of interleukin-1 production |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0005615 | Cellular component | extracellular space |
GO_0072562 | Cellular component | blood microparticle |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0035580 | Cellular component | specific granule lumen |
GO_0005515 | Molecular function | protein binding |
Gene name | ORM1 |
Protein name | Alpha-1-acid glycoprotein 1 (AGP 1) (Orosomucoid-1) (OMD 1) |
Synonyms | AGP1 |
Description | FUNCTION: Functions as a transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability in the body. Appears to function in modulating the activity of the immune system during the acute-phase reaction. . |
Accessions | ENST00000259396.9 P02763 |